Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Liver Neoplasms × sintilimab × Clear all

Status

Unknown 2 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 11 Stomach Neoplasms 9 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Turcot syndrome 1 Thyroid Neoplasms 1 Sarcoma 1 Salivary Gland Malignant Neoplasms 1 Rare Tumor 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasm Metastasis 1 NSCLC 1 Microsatellite Stable Metastatic Colorectal Cancer 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Meningeal Carcinomatosis 1 Lung Squamous Cell Carcinoma 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1

Interventions

Bevacizumab 9 atezolizumab 5 pembrolizumab 4 lenvatinib 4 durvalumab 4 tremelimumab 3 fludarabine 3 camrelizumab 3 apatinib 3 Cyclophosphamide 3 regorafenib 2 Riluzole 2 Radiotherapy 2 Nivolumab 2 Magnetic Resonance Imaging 2 Ipilimumab 2 Blood Specimen Collection 2 yttrium chloride 1 trastuzumab deruxtecan 1 toripalimab 1 spartalizumab 1 sintilimab 1 pertuzumab 1 fludarabine phosphate 1 ferric carboxymaltose 1 epigallocatechin gallate 1 donafenib 1 brodalumab 1 Yttrium-90 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05713994 2025-03-25

CCGLC-001

Tongji Hospital

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡